4.5 Review

ULTRASOUND-RESPONSIVE CAVITATION NUCLEI FOR THERAPY AND DRUG DELIVERY

Journal

ULTRASOUND IN MEDICINE AND BIOLOGY
Volume 46, Issue 6, Pages 1296-1325

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ultrasmedbio.2020.01.002

Keywords

Ultrasound; Cavitation nuclei; Therapy; Drug delivery; Bubble-cell interaction; Sonoporation; Sonothrombolysis; Blood-brain barrier opening; Sonobactericide; Tumor

Funding

  1. European Research Council under the European Union [805308]
  2. Phospholipid Research Center in Heidelberg, Germany
  3. FWO Vlaanderen [12E3916N]
  4. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS047603, R01 HL135092, R01 HL133334]
  5. Engineering and Physical Sciences Research Council [EP/I021795/1, EP/L024012/1]
  6. Canada Research Chair Program
  7. EPSRC [EP/I021795/1, EP/L024012/1] Funding Source: UKRI
  8. European Research Council (ERC) [805308] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Therapeutic ultrasound strategies that harness the mechanical activity of cavitation nuclei for beneficial tissue bio-effects are actively under development. The mechanical oscillations of circulating microbubbles, the most widely investigated cavitation nuclei, which may also encapsulate or shield a therapeutic agent in the bloodstream, trigger and promote localized uptake. Oscillating microbubbles can create stresses either on nearby tissue or in surrounding fluid to enhance drug penetration and efficacy in the brain, spinal cord, vasculature, immune system, biofilm or tumors. This review summarizes recent investigations that have elucidated interactions of ultrasound and cavitation nuclei with cells, the treatment of tumors, immunotherapy, the blood-brain and blood-spinal cord barriers, sonothrombolysis, cardiovascular drug delivery and sonobactericide. In particular, an overview of salient ultrasound features, drug delivery vehicles, therapeutic transport routes and pre-clinical and clinical studies is provided. Successful implementation of ultrasound and cavitation nuclei-mediated drug delivery has the potential to change the way drugs are administered systemically, resulting in more effective therapeutics and less-invasive treatments. (E-mail: k.kooiman@erasmusmc.nl) (C) 2020 The Author(s). Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available